Literature DB >> 2570384

Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease.

A W Procter1, J M Stirling, G C Stratmann, A J Cross, D M Bowen.   

Abstract

Well washed membranes have been prepared from samples of cerebral cortex of control subjects and patients with Alzheimer's disease, obtained both at post mortem and by neurosurgical procedures earlier in the course of the disease. Binding to these membranes of two radioligands for the N-methyl-D-aspartate-phencyclidine receptor complex has been determined in the presence and absence of glycine. Glycine increased the binding in both control and Alzheimer tissue samples. At one concentration of radioligand, in the presence of glycine there was less binding to post-mortem samples, which Scatchard analysis showed was associated with a 36% loss of sites. In rare neurosurgical samples, there was also a loss of binding of radioligand which suggests that the effect is not due to post-mortem artefacts or epiphenomena. These new results may have implications for the symptomatic and preventative treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570384     DOI: 10.1016/0304-3940(89)90441-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.

Authors:  Shirley W Y Tsang; Harry V Vinters; Jeffrey L Cummings; Peter T-H Wong; Christopher P L-H Chen; Mitchell K P Lai
Journal:  Neurobiol Aging       Date:  2007-04-11       Impact factor: 4.673

Review 3.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  D-cycloserine for Alzheimer's disease.

Authors:  K Laake; A R Oeksengaard
Journal:  Cochrane Database Syst Rev       Date:  2002

5.  Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.

Authors:  P T Francis; M N Pangalos; P H Stephens; J R Bartlett; P K Bridges; A L Malizia; D Neary; A W Procter; D J Thomas; D M Bowen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

6.  Glutamate, learning and dementia-selection of evidence.

Authors:  W Danysz; T Archer
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

7.  Brain aging research at the close of the 20th century: from bench to bedside.

Authors:  C Cidis Meltzer; P T Francis
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.